Search

Search Constraints

You searched for: Author/Creator D'Alterio, Crescenzo

Search Results

1. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion. Issue 1 (1st January 2016)

2. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients. Issue 2 (10th January 2014)

3. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. (March 2021)

4. CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis. Issue 14 (17th March 2016)

5. CXCR4–CXCL12–CXCR7, TLR2–TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients. (1st December 2016)

6. HIGH EXPRESSION OF CXCR4 - CXCR7 - CXCL12 PREDICTS POOR SURVIVAL AFTER UP-FRONT RESECTION OF PANCREATIC ADENOCARCINOMA. Issue 2 (February 2023)

8. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. (April 2021)